Data for tumor TMB, categorized based on a cutoff of 5 mutations per megabase (Supplementary material of the SOLACE2 trial: Supplementary note 1, Supplementary Fig. 11), and plasma IFN-γ levels, categorized based on the mean distribution (Supplementary material of the SOLACE2 trial: Supplementary note 1, Supplementary Fig. 12) are also provided. This evidence concerns the gene IFNG and neoplasm.